Cartesian Therapeutics Inc (NAS:RNAC)
$ 17.91 -0.74 (-3.97%) Market Cap: 455.18 Mil Enterprise Value: 250.63 Mil PE Ratio: 0 PB Ratio: 577.74 GF Score: 58/100

Cartesian Therapeutics Inc (RNAC) Transcripts

  • 1